Form 4: GoodRx Officer Vests Shares, Sells for Tax Obligations

GoodRx Chief Accounting Officer Thomas Chan acquired Class A common stock through RSU vesting and subsequently sold a portion to cover tax obligations.

Summary

• Thomas Chan, Chief Accounting Officer of GoodRx Holdings, Inc. (GDRX), reported transactions on June 15, 2026.
• Acquired 1,969 shares of Class A Common Stock through the vesting of restricted stock units (RSUs).
• Disposed of 1,002 shares of Class A Common Stock at a price of $2.65 per share, likely for tax withholding purposes.
• Acquired an additional 2,100 shares of Class A Common Stock through the vesting of restricted stock units.
• Disposed of 1,069 shares of Class A Common Stock at a price of $2.65 per share, also likely for tax withholding.
• Following these transactions, Thomas Chan beneficially owns 5,735 shares of Class A Common Stock directly.
• Still holds 14,707 restricted stock units (RSUs) that represent a contingent right to receive one share of Class A common stock each.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a standard executive compensation event, with no significant positive or negative implications for the company's fundamentals or immediate stock performance.

Positives

• The vesting of restricted stock units indicates continued compensation and retention of a key executive, Thomas Chan.
• The acquisition of shares through RSU vesting increases the executive's direct equity stake in the company, aligning interests with shareholders.

Negatives

• The disposition of 1,002 and 1,069 shares of Class A Common Stock, totaling 2,071 shares, reduces the executive's direct ownership, although these sales are typically for tax purposes.

Future Outlook

The filing indicates ongoing vesting schedules for restricted stock units, with future installments contingent on the reporting person's continued service.

Industry Context

StockSavvy.ai notes that RSU vesting and subsequent 'sell-to-cover' transactions for tax obligations are standard practices in executive compensation across various industries. This filing reflects a routine event for a publicly traded company's executive.

Comparison to Industry Standards

• The practice of granting Restricted Stock Units (RSUs) as part of executive compensation is a common industry standard, aligning executive incentives with long-term shareholder value.
• The 'sell-to-cover' mechanism for tax withholding upon RSU vesting is also a widely accepted and standard procedure for executives across companies like Amazon, Google, and Microsoft, ensuring tax compliance without requiring personal funds.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine compensation event and not a discretionary sale indicating a change in outlook.
• Employees: No direct impact mentioned.

Next Steps

• Continued vesting of the remaining 14,707 restricted stock units according to their respective quarterly schedules, subject to continued service.

Key Dates

Recommendation

This Form 4 reports a routine insider transaction involving RSU vesting and subsequent tax-related sales by a Chief Accounting Officer. Such transactions are common and typically do not signal a change in company fundamentals or management's long-term outlook, thus warranting a 'hold' recommendation based solely on this filing.

Keywords

GoodRx, GDRX, Form 4, Insider Transaction, Restricted Stock Unit, RSU Vesting, Executive Compensation, Stock Sale, Tax Withholding